BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 19647748)

  • 1. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence.
    Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y
    J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of His mutations on the fibrillation of amyloidogenic Vlambda6 protein Wil under acidic and physiological conditions.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    Biochem Biophys Res Commun; 2010 Jan; 391(1):615-20. PubMed ID: 19932684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis.
    Blancas-Mejia LM; Tellez LA; del Pozo-Yauner L; Becerril B; Sanchez-Ruiz JM; Fernandez-Velasco DA
    J Mol Biol; 2009 Mar; 386(4):1153-66. PubMed ID: 19154739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
    Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
    J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
    Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A
    J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monomer-seed interaction mechanism in the formation of the β2-microglobulin amyloid fibril clarified by solution NMR techniques.
    Yanagi K; Sakurai K; Yoshimura Y; Konuma T; Lee YH; Sugase K; Ikegami T; Naiki H; Goto Y
    J Mol Biol; 2012 Sep; 422(3):390-402. PubMed ID: 22683352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and genetic determinants of λ6 light chain amyloidogenesis.
    González-Andrade M; Becerril-Luján B; Sánchez-López R; Ceceña-Álvarez H; Pérez-Carreón JI; Ortiz E; Fernández-Velasco DA; del Pozo-Yauner L
    FEBS J; 2013 Dec; 280(23):6173-83. PubMed ID: 24107228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
    Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
    Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
    J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly amyloidogenic region of hen lysozyme.
    Frare E; Polverino De Laureto P; Zurdo J; Dobson CM; Fontana A
    J Mol Biol; 2004 Jul; 340(5):1153-65. PubMed ID: 15236974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid nucleation triggered by agitation of beta2-microglobulin under acidic and neutral pH conditions.
    Sasahara K; Yagi H; Sakai M; Naiki H; Goto Y
    Biochemistry; 2008 Feb; 47(8):2650-60. PubMed ID: 18211100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme.
    Vernaglia BA; Huang J; Clark ED
    Biomacromolecules; 2004; 5(4):1362-70. PubMed ID: 15244452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
    Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
    J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family.
    Iconomidou VA; Chryssikos GD; Gionis V; Galanis AS; Cordopatis P; Hoenger A; Hamodrakas SJ
    J Struct Biol; 2006 Dec; 156(3):480-8. PubMed ID: 17056273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR.
    Rohrberg J; Sachs R; Lodderstedt G; Sackewitz M; Balbach J; Schwarz E
    FEBS Lett; 2008 May; 582(11):1587-92. PubMed ID: 18406354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil.
    Abe Y; Shibata H; Oyama K; Ueda T
    Int J Biol Macromol; 2021 Jan; 166():342-351. PubMed ID: 33127550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibrillation of human Apaf-1 CARD.
    Rao PN; Reddy KS; Bhuyan AK
    Biochemistry; 2009 Aug; 48(32):7656-64. PubMed ID: 19603830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.